Cargando…

Aspirin-exacerbated Respiratory Disease: A Syndrome of Mast Cell–mediated PgD2 Overproduction

Detalles Bibliográficos
Autor principal:	Borish, Larry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2019
Materias:	Editorials
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775875/ https://www.ncbi.nlm.nih.gov/pubmed/31026400 http://dx.doi.org/10.1164/rccm.201904-0716ED

Ejemplares similares

Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial
por: Hayashi, Hiroaki, et al.
Publicado: (2020)

Aspirin Exacerbated Respiratory Disease
por: Teran, Luis M., et al.
Publicado: (2012)

The Role of Mast Cells in Aspirin-Exacerbated Respiratory Disease (AERD) Pathogenesis: Implications for Future Therapeutics
por: Kuruvilla, Merin E, et al.
Publicado: (2020)

Does IgE Have a Role in Aspirin-exacerbated Respiratory Disease?
por: Busse, William W.
Publicado: (2020)

Rhinosinusitis and Aspirin-Exacerbated Respiratory Disease
por: Garcia Cruz, Maria L., et al.
Publicado: (2012)

Identification of defensin-encoding genes of Picea glauca: characterization of PgD5, a conserved spruce defensin with strong antifungal activity
por: Picart, Pere, et al.
Publicado: (2012)

PGD Synthase and PGD(2) in Immune Resposne
por: Joo, Myungsoo, et al.
Publicado: (2012)

Nasal lysine aspirin challenge in the diagnosis of aspirin - exacerbated respiratory disease
por: Miller, B, et al.
Publicado: (2013)

The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD)()
por: Spies, Jonas Willian, et al.
Publicado: (2015)

Biomarkers for predicting response to aspirin therapy in aspirin‐exacerbated respiratory disease
por: Tyrak, Katarzyna E., et al.
Publicado: (2021)

Platelet Isoprostane Overproduction in Diabetic Patients Treated With Aspirin
por: Cangemi, Roberto, et al.
Publicado: (2012)

Genetic Mechanisms in Aspirin-Exacerbated Respiratory Disease
por: Shrestha Palikhe, Nami, et al.
Publicado: (2012)

Aspirin-Exacerbated Respiratory Disease: Evaluation and Management
por: Lee, Rachel U., et al.
Publicado: (2011)

Update on the Management of Aspirin-Exacerbated Respiratory Disease
por: Buchheit, Kathleen M., et al.
Publicado: (2016)

Aspirin‐exacerbated respiratory disease: A review
por: Dominas, Christine, et al.
Publicado: (2020)

A Complicated Case of Aspirin-Exacerbated Respiratory Disease With Kounis Syndrome
por: Shaw, Krista M, et al.
Publicado: (2023)

Prostaglandin D(2) (PGD(2)); PGD(2) receptor subtype DP1
Publicado: (2011)

Audit of nasal lysine aspirin therapy in recalcitrant aspirin exacerbated respiratory disease
por: Howe, Rachel, et al.
Publicado: (2014)

The Roles of Type 2 Cytotoxic T Cells in Inflammation, Tissue Remodeling, and Prostaglandin (PG) D(2) Production Are Attenuated by PGD(2) Receptor 2 Antagonism
por: Chen, Wentao, et al.
Publicado: (2021)

An Overproduction of Scholars
Publicado: (1893)

The utility of biomarkers in diagnosis of aspirin exacerbated respiratory disease
por: Comhair, Suzy A. A., et al.
Publicado: (2018)

Aspirin Exacerbated Respiratory Disease: Epidemiology, Pathophysiology, and Management
por: Li, Kevin L., et al.
Publicado: (2019)

Appropriate extent of surgery for aspirin-exacerbated respiratory disease
por: Muhonen, Ethan G., et al.
Publicado: (2020)

Aspirin-exacerbated respiratory disease: Update on medical management
por: White, Andrew A., et al.
Publicado: (2020)

Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease
por: Sehanobish, Esha, et al.
Publicado: (2021)

Aspirin Exacerbated Respiratory Disease and Nasal Polyp Phenotyping
por: Kaboodkhani, Reza, et al.
Publicado: (2021)

Update on Recent Advances in the Management of Aspirin Exacerbated Respiratory Disease
por: Palikhe, Nami Shrestha, et al.
Publicado: (2009)

Aspirin-exacerbated respiratory disease: pathophysiological insights and clinical advances
por: Steinke, John W, et al.
Publicado: (2016)

Exonic Variants Associated with Development of Aspirin Exacerbated Respiratory Diseases
por: Shin, Seung-Woo, et al.
Publicado: (2014)

Pathogenesis of NSAID-induced reactions in aspirin-exacerbated respiratory disease
por: Laidlaw, Tanya M.
Publicado: (2018)

Dupilumab increases aspirin tolerance in NSAID-exacerbated respiratory disease
por: Schneider, Sven, et al.
Publicado: (2023)

Clinical and Immunological Efficacy of Aspirin Desensitization in Nasal Polyp Patients with Aspirin-Exacerbated Respiratory Disease
por: Mortazavi, Negar, et al.
Publicado: (2017)

The impact of endoscopic sinus surgery and aspirin desensitization on psychological burden in aspirin-exacerbated respiratory disease
por: Locke, Tran, et al.
Publicado: (2020)

Network analysis of PGD, PTSD and insomnia symptoms in Chinese shidu parents with PGD
por: Xu, Xin, et al.
Publicado: (2022)

Leptin Elicits In Vivo Eosinophil Migration and Activation: Key Role of Mast Cell-Derived PGD(2)
por: Amorim, Natália R. T., et al.
Publicado: (2020)

Aspirin induces IL-4 production: augmented IL-4 production in aspirin-exacerbated respiratory disease
por: Kong, Su-Kang, et al.
Publicado: (2016)

Systematic review of outcomes for endoscopic sinus surgery and subsequent aspirin desensitization in aspirin-exacerbated respiratory disease
por: Ryan, Lindsey, et al.
Publicado: (2020)

Biomarkers for predicting response to long‐term high dose aspirin therapy in aspirin‐exacerbated respiratory disease
por: Mastalerz, Lucyna, et al.
Publicado: (2021)

A Comparison of Sphenoid Sinus Osteoneogenesis in Aspirin-Exacerbated Respiratory Disease
por: Malfitano, Madison J., et al.
Publicado: (2020)

COVID-19 in a series of patients with aspirin-exacerbated respiratory disease
por: White, Andrew A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s3n45a6ra7dmdbkhlsri0mqu3v